Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial
- 5 July 2003
- journal article
- clinical trial
- Published by Elsevier
- Vol. 362 (9377) , 14-21
- https://doi.org/10.1016/s0140-6736(03)13801-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) study: Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failureInternational Journal of Cardiology, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Medical and Cellular Implications of Stunning, Hibernation, and PreconditioningCirculation, 1998
- Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart DiseasePublished by Elsevier ,1998
- Assessment of Myocardial Viability With 99m Tc Sestamibi in Patients Undergoing Cardiac TransplantationCirculation, 1996
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trialJournal of the American College of Cardiology, 1994
- Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.Circulation, 1991
- The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathyAmerican Heart Journal, 1983